Prognostic value of a biologic classification of non-small-cell lung cancer into the growth patterns along with other clinical, pathological and immunohistochemical factors

European Journal of Cardio-thoracic Surgery

Volumn 38, Issue 5, 2010, Pages 628-636

  Sardari Nia, Peyman ^a   Van Marck, Eric ^a   Weyler, Joost ^a   Van Schil, Paul ^a  

^a ANTWERP UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Growth pattern; NSCLC

Indexed keywords

CD34 ANTIBODY; EOSIN; HEMATOXYLIN; MONOCLONAL ANTIBODY KI 67;

ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER GROWTH; CANCER RECURRENCE; CANCER SURVIVAL; CELL PROLIFERATION; COMORBIDITY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; ENDOTHELIUM CELL; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG ALVEOLUS CELL CARCINOMA; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MICROVASCULATURE; OVERALL SURVIVAL; PAPILLARY CARCINOMA; PATHOLOGY; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; QUESTIONNAIRE; RETROSPECTIVE STUDY; SMOKING; STATISTICAL SIGNIFICANCE;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; CELL PROLIFERATION; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; SMOKING; TUMOR MARKERS, BIOLOGICAL;

EID: 77957908635     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejcts.2010.03.015     Document Type: Article

References (18)

1. Parkin D.M., Bray F., Ferlay J., Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005, 55:74-108.
2. Mountain C. Revisions in the international system for staging lung cancer. Chest 1997, 111:1710-1717.
3. Sardari Nia P., Van Marck E., Van Schil P. The prospect of biologic staging of non-small-cell lung cancer. Clin Lung Cancer 2005, 6:217-224.
4. Sardari Nia P., Colpaert C., Blyweert B., Kui B., Vermeulen P., Ferguson M., Hendriks J., Weyler J., Pezzella F., Van Marck E., Van Schil P. Prognostic value of nonangiogenic and angiogenic growth patterns in non-small cell lung cancer. Br J Cancer 2004, 91:1293-1300.
5. Sardari Nia P., Colpaert C., Vermeulen P., Weyler J., Pezzella F., Van Schil P., Van Marck E. Different growth patterns of non-small cell lung cancer represent distinct biologic subtypes. Ann Thorac Surg 2008, 85:395-405.
6. Sardari Nia P., Hendriks J., Friedel G., Van Schil P., Van Marck E. Distinct angiogenic and non-angiogenic growth patterns of lung metastases from renal cell carcinoma. Histopathology 2007, 51:354-361.
7. Brambilla E., Travis W.D., Colby T.V., Corrin B., Shimosato Y. The new World Health Organization classification of lung tumours. Eur Respir J 2001, 18:1059-1068.
8. Charlson M.E., Pompei P., Ales K.L., MacKenzie C.R. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987, 40:373-383.
9. Birim O., Maat A.P., Kappetein A.P., van Meerbeeck J.P., Damhuis R.A., Bogers A.J. Validation of the Charlson comorbidity index in patients with operated primary non-small cell lung cancer. Eur J Cardiothorac Surg 2003, 23:30-34.
10. Ambrogi V., Pompeo E., Elia S., Pistolese G.R., Mineo T.C. The impact of cardiovascular comorbidity on the outcome of surgery for stage I and II non-small-cell lung cancer. Eur J Cardiothorac Surg 2003, 23:811-817.
11. Battafarano R.J., Piccirillo J.F., Meyers B.F., Hsu H.S., Guthrie T.J., Cooper J.D., Patterson G.A. Impact of comorbidity on survival after surgical resection in patients with stage I non-small cell lung cancer. J Thorac Cardiovasc Surg 2002, 123:280-287.
12. Birim Ö., Kappetein A.P., Bogers A.J.J.C. Charlson comorbidity index as a predictor of long-term outcome after surgery for non-small cell lung cancer. Eur J Cardiothorac Surg 2005, 28:759-762.
13. Fujisawa T., Iizasa T., Saitoh Y., Sekine Y., Motohashi S., Yasukawa T., Shibuya K., Hiroshima K., Ohwada H. Smoking before surgery predicts poor long-term survival in patients with stage I non-small-cell lung carcinomas. J Clin Oncol 1999, 17:2086-2091.
14. Tammemagi C.M., Neslund-Dudas C., Simoff M., Kvale P. Smoking and lung cancer survival: the role of comorbidity and treatment. Chest 2004, 125:27-37.
15. Sardari Nia P., Weyler J., Colpaert C., Vermeulen P., Van Marck E., Van Schil P. Prognostic value of smoking status in operated non-small cell lung cancer. Lung Cancer 2004, 47:351-359.
16. Van den Eynden G.G., Colpaert C.G., Couvelard A., Pezzella F., Dirix L.Y., Vermeulen P.B., Van Marck E.A., Hasebe T. A fibrotic focus is a prognostic factor and a surrogate marker for hypoxia and (lymph)angiogenesis in breast cancer: review of the literature and proposal on the criteria of evaluation. Histopathology 2007, 51:440-451.
17. Shimosato Y., Suzuki A., Hashimoto T., Nishiwaki Y., Kodama T., Yoneyama T., Kameya T. Prognostic implications of fibrotic focus (scar) in small peripheral lung cancers. Am J Surg Pathol 1980, 4:365-373.
18. Noguchi M., Morikawa A., Kawasaki M., Matsuno Y., Yamada T., Hirohashi S., Kondo H., Shimosato Y. Small adenocarcinoma of the lung. Histologic characteristics and prognosis. Cancer 1995, 75:2844-2852.